Aytu BioPharma, Inc. (AYTU) vs InspireMD, Inc. (NSPR)
A side-by-side comparison of Aytu BioPharma, Inc. and InspireMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AYTU
Aytu BioPharma, Inc.
$2.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NSPR
InspireMD, Inc.
$0.53HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AYTU vs NSPR
growth of $100 · dividends reinvested · last 10yAYTU -100.0% (-68.9%/yr)NSPR -100.0% (-68.2%/yr)NSPR compounded faster over this window
AYTU NSPR
AYTU vs NSPR: by the numbers
- •NSPR is the larger company ($25M vs $22M market cap).
- •Both run net losses; AYTU's is the smaller (-24.76% vs -355.17% net margin).
- •NSPR grew revenue faster over the past five years (27.79% vs -2.59% CAGR).
Metrics side by side
Valuation
| Metric | AYTU | NSPR |
|---|---|---|
| P/S ratio | 0.38 | 2.27 |
| P/B ratio | 0.62 | 0.78 |
| FCF yield | 14.78% | N/A |
Profitability
| Metric | AYTU | NSPR |
|---|---|---|
| Gross margin | 63.95% | 29.50% |
| Operating margin | -14.44% | -546.97% |
| Net margin | -24.76% | -355.17% |
| ROE | -40.40% | -122.19% |
| ROIC | -14.21% | -153.04% |
Growth (annualized)
| Metric | AYTU | NSPR |
|---|---|---|
| Revenue CAGR (5Y) | -2.59% | 27.79% |
| Total return CAGR (5Y) | -48.14% | -36.91% |
Frequently asked
- Which has grown faster, AYTU or NSPR?
- Over the past five years, NSPR grew revenue faster — AYTU at a -2.59% CAGR versus NSPR at 27.79%.
- How have AYTU and NSPR total returns compared?
- Over the past 10 years, AYTU delivered -68.87% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Aytu BioPharma ROEInspireMD ROEAytu BioPharma operating marginInspireMD operating marginAytu BioPharma revenue growthInspireMD revenue growthAytu BioPharma free cash flowInspireMD free cash flow
Aytu BioPharma & InspireMD appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.